期刊文献+

加味当归补血汤对慢性心力衰竭伴贫血患者生活质量的影响 被引量:11

Effect of Supplemented Angelica Blood-Tonifying Decoction on Quality of Life of Patients with Chronic Heart Failure Combined with Anemia
下载PDF
导出
摘要 目的:观察加味当归补血汤对慢性心力衰竭伴发贫血患者生活质量的影响。方法:选取我院72例慢性心力衰竭伴发贫血患者,随机分为对照组和治疗组,每组36例。对照组给予常规西药治疗,治疗组在常规治疗的同时联合应用加味当归补血汤,2组均治疗4周。观察2组患者治疗前后中医症状积分、血色素(Hb)、左心室射血分数(LVEF)、明尼苏达心功能不全生活质量量表(MLHFQ)积分。结果:2组治疗后,治疗组证候疗效总有效率为80.56%,对照组为55.56%,治疗组疗效优于对照组(P<0.05);治疗组与对照组比较,Hb显著升高、MLHFQ积分下降,差异有统计学意义(P<0.05)。结论:加味当归补血汤能纠正慢性心力衰竭患者的贫血、改善心功能,提高生活质量。 Objective: To observe the effect of Supplemented Angelica Blood-Tonifying Decoction on quality of life of patients with chronic heart failure combined with Anemia. Methods: Total 72 cases of chronic heart failure combined with anemia were randomized into treatment group( 36 cases) and control group( 36 cases). Treatment group was given Supplemented Angelica Blood-Tonifying Decoction on the basis of western medicine,control group was given western routine medicine,both groups were treated for 4weeks. Before and after treatment,Chinese medicine symptom score,hemoglobin,LVEF,MLHFQ score were observed. Results:The total effective rate of symptom score of the treatment group and control group was 80. 56% and 55. 56% respectively,with significant difference between the two groups( P 〈0. 05). The levels of Hb in both groups were improved after treatment,especially in the treatment group( P〈 0. 05),the scores of MLHFQ in both groups decreased after treatment,especially in the treatment group( P 〈0. 05). Conclusion: Supplemented Angelica Blood-Tonifying Decoction could correct anemia in chronic heart failure patients,as well as improve heart function and quality of life.
出处 《世界中医药》 CAS 2016年第7期1242-1244,共3页 World Chinese Medicine
基金 国家自然科学基金青年项目(编号:81302964/H2708)
关键词 慢性心力衰竭 贫血 加味当归补血汤 生活质量 Chronic Heart Failure Anemia Supplemented Angelica Blood-Tonifying Decoction Quality of life
  • 相关文献

参考文献2

二级参考文献56

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.
  • 10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331.

共引文献3678

同被引文献133

引证文献11

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部